Comparisons of tumor-infiltrating lymphocyte levels and the 21-gene recurrence score in ER-positive/HER2-negative breast cancer

被引：0
|
作者：
Sung Gwe Ahn
Yoon Jin Cha
Soon June Bae
Chanik Yoon
Hak Woo Lee
Joon Jeong
机构：
[1] Yonsei University College of Medicine,Department of Surgery, Gangnam Severance Hospital
[2] Yonsei University College of Medicine,Department of Pathology, Gangnam Severance Hospital
来源：
BMC Cancer | / 18卷
关键词：
Tumor-infiltrating lymphocytes; 21-gene recurrence score; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
    Dowsett, Mitch
    Sestak, Ivana
    Buus, Richard
    Lopez-Knowles, Elena
    Mallon, Elizabeth
    Howell, Anthony
    Forbes, John F.
    Buzdar, Aman
    Cuzick, Jack
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2763 - 2770
  • [22] Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer
    Jung, Wonguen
    Kim, Kyubo
    Moon, Byung-In
    BREAST CARE, 2022, 17 (06) : 561 - 566
  • [23] Challenges in the management of advanced, ER-positive, HER2-negative breast cancer
    Christopher D. Hart
    Ilenia Migliaccio
    Luca Malorni
    Cristina Guarducci
    Laura Biganzoli
    Angelo Di Leo
    Nature Reviews Clinical Oncology, 2015, 12 : 541 - 552
  • [24] Palbociclib and letrozole for ER-positive, HER2-negative advanced breast cancer
    Abraham, Jame
    Mechcatie, Elizabeth
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (03): : 83 - 86
  • [25] Challenges in the management of advanced, ER-positive, HER2-negative breast cancer
    Hart, Christopher D.
    Migliaccio, Ilenia
    Malorni, Luca
    Guarducci, Cristina
    Biganzoli, Laura
    Di Leo, Angelo
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (09) : 541 - 552
  • [26] Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
    Miglietta, Federica
    Dieci, Maria Vittoria
    Giarratano, Tommaso
    Torri, Valter
    Giuliano, Mario
    Zustovich, Fable
    Mion, Marta
    Tondini, Carlo Alberto
    De Rossi, Costanza
    Bria, Emilio
    Franchi, Michela
    Merlini, Laura
    Giannatiempo, Rosa
    Russo, Daniela
    Fotia, Vittoria
    Poletti, Paola
    Caremoli, Elena Rota
    Arpino, Maria Grazia
    De Salvo, Gian Luca
    Zambelli, Alberto
    Guarneri, Valentina
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [27] Clinical impact of tumor infiltrating lymphocytes and neutrophil-lymphocyte ratio in estrogen receptor-positive/HER2-negative breast cancer patients with high 21-gene signature recurrence scores
    Kanaoka, Haruka
    Nagahashi, Masayuki
    Ishikawa, Eri
    Bun, Ayako
    Fukui, Reiko
    Ozawa, Hiromi
    Higuchi, Tomoko
    Natori, Keiko
    Imamura, Michiko
    Takatsuka, Yuichi
    Miyoshi, Yasuo
    CANCER RESEARCH, 2022, 82 (04)
  • [28] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [29] 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer
    Zhang, Wen-Wen
    Tong, Qin
    Sun, Jia-Yuan
    Hua, Xin
    Long, Zhi-Qing
    Deng, Jia-Peng
    Dong, Yong
    Li, Fang-Yan
    He, Zhen-Yu
    Wu, San-Gang
    Lin, Huan-Xin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [30] Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients
    Wu Jiayi
    Fang Yan
    Lin Lin
    Fei Xiaochun
    Gao Weiqi
    Zhu Siji
    Zong Yu
    Chen Xiaosong
    Huang Ou
    He Jianrong
    Zhu Li
    Chen Weiguo
    Li Yafen
    Shen Kunwei
    ONCOTARGET, 2017, 8 (24) : 38706 - 38716
12345